ArticleHaematologica2023

Modified carfilzomib dosing is associated with improved treatment responses and longer time on treatment in patients with multiple myeloma.

Abdullah M Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.